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Isolation and crystallization of PvdJp2, 
a non-ribosomal peptide synthetase 
domain in Pseudomonas aeruginosa 
Betsy Ramirez
Q&A
How did you become involved in doing research?
I transferred to KU from a community college that did not emphasize 
research experience at all, so I was surprised and excited by the emphasis on 
research at KU. I contacted Dr. Lamb through email, expressing interest in 
the work she was doing, and was invited into her lab for a trial period. I fell 
in love with the research, and was excited to work on my own project.
How is the research process different from what you expected?
In order to scratch the surface of the research I was doing, I had to do a lot 
of research in the literature. I was definitely surprised by how much reading 
(and rereading!) it took for me to really get a better understanding of my 
research topic.
What is your favorite part of doing research?
Research is an inquiry driven field—I enjoy the process of asking a question 










Audrey Lamb, Associate Professor of 
Molecular Biosciences
ABSTRACT
During times of iron deprivation, many bacteria produce low molecular weight compounds called 
siderophores, which have the ability to scavenge iron from the host environment. Pyoverdin is a siderophore 
produced by Pseudomonas aeruginosa during extreme iron starvation. The biosynthesis of pyoverdin involves 
several multi-modular non-ribosomal Peptide Synthetases (NRPSs). The NRPS PvdJ incorporates two 
amino acids into the growing pyoverdin. PvdJp2 is a structural domain within the second module of PvdJ 
that acts as a scaffold and tether for the incorporation of formyl-hydroxyornithine. Present work is focusing 
on the expression, purification, and crystallization of PvdJp2. PvdJp2 was determined to express best after 
induction at 30°C for 22 hours, and is purified using standard chromatography techniques, exploiting the 
His-tag. Current methods of crystallization have not yet yielded diffraction quality crystals. Future work will 
focus on alternative methods of crystallization, such as increasing the protein concentration and changing 
the incubation temperature.
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INTRODUCTION
Bacterial pathogens pose a major 
risk to the human population 
due to the increasing prevalence 
of multi-drug resistant bacterial 
strains. The opportunistic pathogen 
Pseudomonas aeruginosa is a Gram 
negative rod that attacks hosts 
with weakened immune systems. 
P. aeruginosa causes 10-15% of 
hospital-acquired infections 
worldwide due to the breakdown of 
physical barriers and high numbers 
of immunocompromised or elderly 
patients in hospitals (Strateva and 
Yordanov, 2009). Examples of typical 
Pseudomonas patients are burn victims, 
cystic fibrosis patients, and AIDS 
patients. Pseudomonas infections have 
been found in 80% of cystic fibrosis 
patients over 18 and are considered 
to be a major factor in their mortality 
(Conova, 2003). In addition, P. 
aeruginosa bacteremia carries a 31% 
mortality rate (Tacconelli et al., 2002)
As a significant hospital-
acquired pathogen, Pseudomonas 
possesses many antibiotic resistance 
strategies—both innate and adapted 
from the environment (Strateva 
and Yordanov, 2009). P. aeruginosa 
intrinsically contains efflux pumps 
to pump out antibiotics almost as 
quickly as they are imported in. In 
addition, P. aeruginosa contains 
AmpC Beta-lactamase, which targets 
Penicillin-derived antibiotics by 
breaking apart a signature bond in 
their unique structure. Pseudomonas 
also has the ability to acquire 
resistance from the environment 
through horizontal gene transfer—
which is the uptake of genetic 
material from the environment. It 
has been reported by Pechere and 
Kohler (1999) that P. aeruginosa is 
considered a “phenomenon” for 
having demonstrated almost all 
known enzymatic and mutational 
mechanisms for resistance. Multi-
Drug resistance has emerged in 
27-72% of patients infected with 
initially susceptible Pseudomonas 
isolates (Obritsch, Fish, MacLaren, 
and Jung, 2005). 
One of the virulence factors 
that Pseudomonas possesses is the 
ability to produce siderophores, 
low molecular weight compounds 
released by the bacterium into the 
environment to scavenge iron for 
metabolic purposes. Iron, while 
abundant in the human body, is 
typically bound to hemoglobin, 
myoglobin, or cytochrome (Jurado, 
1997). Additional iron is held by 
iron-sequestering proteins such as 
transferrin, lactoferrin, and ferritin. 
Therefore, the amount of free iron 
within the host is much less than 
what the bacteria requires to carry 
out its functions. In response to 
this, many bacteria have developed 
strategies to scavenge iron from 
the hosts’ environment for essential 
metabolic processes (Jurado, 1997).
P. aeruginosa produces two types 
of siderophores: pyoverdin and 
pyochelin (Dumas, Ross-Gillespie, 
Kummerli, 2013). Pyoverdin 
production is energetically expensive, 
but highly efficient. Pyochelin is 
energetically inexpensive, but not 
as efficient. Pyoverdin is produced, 
therefore, during extreme iron 
deprivation, while pyochelin is 
produced during less extreme iron 
limitation. It has been found that 
alternating between these two 
siderophores allows the bacteria to 
survive in a wide range of conditions 
(Dumas et al., 2013). In this paper, 
the focus will be on pyoverdin 
biosynthesis.
Many siderophore biosynthesis 
pathways utilize non-ribosomal 
Peptide Synthetases (NRPSs), which 
are currently a hot topic in research. 
As indicated by their name, these 
enzymes do not use ribosomes to 
create proteins. Ribosomes are almost 
exclusively used to create proteins 
in nature, and work by binding to 
a specific template and translating 
the message from one biological 
“language” to another. This translation 
results in a protein product. Because 
they use a template, ribosomes must 
adhere to very specific rules regarding 
the types of molecules they will 
interact with. Alternatively, NRPSs are 
composed differently and therefore 
have more freedom to work with 
diverse molecules. Therefore, bioactive 
peptides generated by NRPS enzymes 
are incredibly diverse structurally due 
to their ability to incorporate unusual 
amino acids into their product. These 
amino acids can then be further 
modified by other biological processes 
(Mootz et al., 2002). 
Non-ribosomal Peptide 
Synthetases are independent of 
nucleic acid templates and instead 
work by coordinating catalytic 
centers and using assembly-line 
production (Marahiel and Essen, 
2009). Each module is responsible for 
a specific addition to the final peptide 
Fig. 1. Sequence of PvdJ non-ribosomal Peptide Synthetase domains. Module 1 
incorporates Lysine, and Module 2 incorporates formyl-hydroxyornithine into 
the growing pyoverdine (Ravel and Cornelis 2003).
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product. Each module contains three 
principle domains: the Adenylation 
(A) domain, which recognizes and 
activates the amino acid, the Peptidyl 
Carrier (PCP) domain, which acts as 
a scaffold and tether to the activated 
amino acid, and the Condensation 
(C) domain, which catalyzes peptide 
bond formation to join neighboring 
amino acids (Marahiel and Essen, 
2009). The terminal module also may 
contain an additional domain, the 
Thioesterase domain, which releases 
the finished peptide from the enzyme 
(Ravel and Cornelis, 2003).
The protein domain studied in 
this paper is PvdJp2, a domain of a 
linear NRPS involved in pyoverdin 
biosynthesis in Pseudomonas 
aeruginosa. PvdJp2 is a PCP domain 
of an NRPS that catalyzes the 
addition of the traditional amino 
acid lysine and non-traditional 
amino acid formyl-hydroxyornithine 
into the growing pyoverdin chain. 
Linear NRPSs have the three 
aforementioned core domains 
arranged as C – A – PCP in an 
“elongation module” (Mootz et 
al., 2002) (Fig. 1). The peptides 
produced by linear NRPSs are 
entirely dependent on the order and 
the number of modules involved in 
the pathway, and therefore carry the 
possibility for creating novel products 
by the process of “module swapping” 
(Mootz et al., 2002).
The overall goal of this project 
was to characterize the structure 
of the protein domain PvdJp2. 
Understanding the structure of 
proteins allows for researchers to 
seek further information about how 
they interact with other molecules 
and substrates. In order to determine 
the structure, several steps must 
be taken. The protein must first be 
grown in very specific conditions 
that will allow optimum expression. 
These conditions vary depending on 
the protein, and therefore must be 
determined by methodical testing. 
Once over-expression patterns are 
determined for the protein, it must 
be purified from other proteins. The 
purified protein is then subjected to 
crystallization procedures, which can 
potentially induce the precipitation 
of the protein out of solution in a 
crystalline pattern. The protein crystal 
can then be collected and analyzed 
with X-Ray crystallography in order 
to create a 3-dimensional structure 
using computer analysis. 
METHODS
See online appendix at 
http://ugresearch.ku.edu/Ramirez
RESULTS
The N-PvdJp2 protein overexpression 
plasmid was obtained from Dr. 
Kathleen Meneely. All further 
work on the overexpression and 
purification of N-PvdJp2 was 
completed by the author. 
In order to determine the 
optimum conditions for N-PvdJp2 
overexpression, an induction test 
was performed (Fig. 1). Results from 
the induction test indicated that two 
conditions led to optimal expression 
of N-PvdJp2: 
 1. Overnight growth at 15°C after 
being induced.
2. Overnight growth at 30°C after 
being induced. 
Based on the relative darkness 
of the bands on the gel, it appeared 
as though growth at 30°C yielded 
slightly more protein at the 
appropriate molecular weight. All 
further tests with N-PvdJp2 were 
grown under these conditions.
The purification process 
was carried out using standard 
chromatography techniques, 
exploiting the His-tag. 
Chromatography is a collective 
term used to describe the different 
processes used to separate mixtures. 
The Nickel column binds the His-tag 
(a string of 6 
Histidine amino acids that have 
a high affinity for nickel) selectively 
in order to allow for non-specific 
proteins to flow through (Bornhorst 
and Falke, 2000). Elution of N-PvdJp2 
occurs when high imidazole is 
applied to the column, outcompeting 
N-PvdJp2 for binding sites and 
allowing the tagged protein to wash 
off the column in a single peak 
(Bornhorst and Falke, 2000). The 
fractions from this peak can then 
be combined and applied to a gel 
filtration column. Figure 3 illustrates 
the collection of N-PvdJp2 from 
fractions 47-65. The gel filtration 
column contains porous beads, 
which allow small molecules to 
diffuse slowly through the pores (Gel 
Filtration, n.d.). Larger molecules 
are not able to diffuse through the 
pores, and consequently move 
much quicker through the column. 
Gel filtration does not contain 
any denaturants, and therefore 
discriminates on the basis of 
molecular weight and 3-dimensional 
folding. Therefore, if dimers or 
tetramers of a protein of interest 
form, they will come out before the 
monomer, unlike during SDS-PAGE 
analysis (Gel Filtration, n.d.). Figure 
4 shows that the last peak, sample 
16, represents a monomer form of 
N-PvdJp2. Samples 15-17 were 
collected for concentration.
Buffer optimization screens were 
run on N-PvdJp2 to determine the 
optimum solubility for N-PvdJp2 
Fig. 2. Coomassie stained SDS-PAGE
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Fig. 4. Chromatogram and gel from 
Size Exclusion Column
On the Y-axis is Absorbance measured in 
mAU and on the X-axis is volume measured 
in milliliters. My protein is indicated with an 
arrow and began eluting at 152 minutes.
Fig. 3. Chromatogram and gel from 
Nickel Column
On the Y-axis is Absorbance measured in 
mAU, and on the X-axis is volume measured 
in milliliters. My protein is indicated with the 
arrow and began eluting at 62 minutes.
Table 3. Buffer optimization screen with N-PvdJp2. The addition 
of glycerol to Buffer A resulted in an increase in absorbance, and 
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in solution. When running a buffer 
screen, researchers are looking for 
high absorbency readings, indicating 
that the protein is soluble in solution 
and will therefore be present at 
higher concentrations when running 
crystal screen analysis. Results 
(pictured in Table 3) showed that in 
25mM Tris pH 8, 5mM imidazole, 
500mM NaCl, and 10% glycerol 
(Buffer A) solution N-PvdJp2 showed 
an absorbency of 0.199, comparable 
to the Buffer B solution of 50mM Tris 
pH 8, 150mM Sodium Citrate, and 
10% glycerol at 0.218. N-PvdJp2 
elutes at a concentration of 160mM 
Imidazole from the nickel chelating 
column. The resulting solution led 
to protein aggregates, most likely 
due to the high salt. Therefore, after 
being collected from the nickel 
chelating column, the protein was 
combined with equivalent amounts 
of Buffer B and concentrated with 
a stir cell. The addition of buffer 
before concentrating increased the 
protein collection significantly. After 
a complete preparation of Nickel 
and Gel filtration, 4mg of protein 
is prepared per liter of culture. The 
protein is determined to be 85% 
pure as estimated by coomassie gel. 
Protein was concentrated to 25mg/
mL and stored at -80ºC until used in 
crystal screens. 
Crystal trials were run with 
PvdJp2 in different conditions and 
concentrations. Trials included 
MCSG (Microlytic), Wizard 
(Emerald Biosciences) and Peg 
(Hampton Research). Crystal trials 
have thus far yielded no crystals 
suitable for X-ray analysis. 
DISCUSSION
Great progress has been made in the 
characterization of PvdJp2. Optimum 
expression conditions and buffer 
screen analysis has led to a greater 
understanding of the purification 
process. In addition, crystal screens 
that do not yield diffraction-quality 
crystals have been ruled out from 
further study. 
Once PvdJp2 has been 
characterized through X-Ray 
crystallography, it will provide further 
information about Peptidyl-Carrier 
Domains in NRPSs. As previously 
mentioned, NRPSs are presenting 
new options for antibiotic synthesis 
due to their ability to incorporate 
novel amino acids as well as the 
practical application of shifting the 
domains within a module to change 
the order of substrate incorporation 
(Doekel and Marahiel, 2000). 
Determining the 3-dimensional 
structure of PvdJp2 is a small portion 
of the larger objective that the lab 
is trying to accomplish. PvdJ, as 
aforementioned, is a large, multi-
enzyme complex composed of two 
full modules. Each of these modules 
incorporates a specific amino acid in 
a unidirectional fashion. The Lamb 
lab is currently working on several 
domains within PvdJ, including the 
full first module (PvdJm1), and the 
first PCP domain (PvdJp1). Once 
the 3-dimensional structures of each 
of these components have been 
determined, the lab can begin further 
work on analyzing where exactly the 
specificity for amino acid recognition 
comes from. Present research 
literature proposes mixed theories 
on whether it is the A domain or the 
C domain that confers specificity, as 
discussed below. 
The Adenylation domain has been 
reported in many research studies as 
being responsible for recognition. In 
the article “Design and application 
of multi-modular synthetases,” the 
authors report that the A domain is 
responsible for substrate recognition 
and adenylation driven by ATP 
consumption (Mootz and Marahiel, 
1999). In another publication, the 
Adenylation domains are referred to 
as the “specificity conferring code” of 
NRPS systems (Stachelhaus et al., 
1999). Ackerly and Lamont further 
this opinion, with the statement that 
A domains “provide active sites for the 
recognition and adenylation activation 
of a substrate amino acid” (2004). 
A contrasting opinion is presented 
in the article “Construction of hybrid 
peptide synthetases,” in which the 
authors state that while the C domain 
was not influential in selecting for 
specific amino acids, it is influential in 
“selectivity at the acceptor position of 
the C-domain of NRPSs for the correct 
stereoisomer” (Mootz et al., 2000). This 
selectivity shows a lower selectivity at 
the Donor site but a greater selectivity 
at the Acceptor site (Belshaw et al., 
1999). This discovery indicates that the 
C domain is more selective towards 
the amino acids in the same module 
compared to amino acids in upstream 
modules (Lautru and Challis, 2004). 
In addition, low selectivity due to side 
chain size has also been observed 
(Ehmann et al., 2000). 
A further goal for the overall PvdJ 
project would be to study the effect 
on swapping domains. Research 
has shown that domains can be 
swapped by fusion of linker regions 
and yield different products. Module 
fusions have been demonstrated to 
be increasingly effective, especially 
when the addition is within the linker 
region, where mutations, additions, 
deletions, and substitutions have no 
effect on the integrity of the NRPS 
(Doekel et al., 2008). Studies with 
Daptomycin have revealed efficiency 
of module exchanges exploiting the 
linker region to be as high as 50% 
(Nguyen et al., 2010). 
Investigation of activity, specificity, 
and module or domain swapping 
will depend on the isolation and 
purification of each of the PvdJ 
domains. 3-dimensional modeling 
will provide additional insight into 
the functionality of these domains by 
providing a greater understanding of 
binding regions, conserved regions, 
and catalytic centers. In order to 
determine the structure of PvdJp2, 
further work must be done on 
crystal screen optimizations. Once 
determined, the structure can play 
a role in a greater understanding of 
NRPS systems and analysis. 
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